Sue Ward

BA (Durham)

School of Health and Related Research


Research Associate
+44 114 222 0816

Full contact details

Sue Ward
School of Health and Related Research
Regent Court (ScHARR)
30 Regent Street
S1 4DA

I graduated with an Economics degree from Durham University. After working in marketing and operational research with the electricity industry I moved to the University of Sheffield in 1994. My main area of interest is economic evaluation in health care, with a particular focus on economic modelling of cancer therapies.

Economic evaluation in cancer

I have been a major contributor to the HEDS section input to rapid review projects in the cancer field for the National Institute for Health and Clinical Excellence (NICE), including the cost effectiveness of gemcitabine in pancreatic cancer, oral drugs for advanced colorectal cancer and hormonal therapies and taxanes for early breast cancer. I have also led a series of economic evaluations of new guidance for the management and treatment of a range of cancers (including upper gastro-intestinal cancers, haematological, cancers and breast cancer) for the Department of Health in England and Wales, along with an economic evaluation of the recent guidance on supportive and palliative care. In addition I have been involved in a series of industry funded projects for cancer treatment in the field of chronic myeloid leukaemia, gastro-intestinal stromal tumours and renal cell carcinoma and worked on a HTA project relating to the cost effectiveness of enhanced imaging techniques for assessment of axillary lymph node metastases.

Coronary heart disease

Developing on work undertaken in 1997 and 1998 on the roles of statins in coronary heart disease and the development of a decision support tool for evaluation of alternative policies on HMG Co-A Reductase Inhibitor (Statin) prescribing, I led a Health Technology Assessment for statins in the prevention of cardiovascular events.

Work in other disease areas

I have also managed a number of projects in non-cancer related areas, including a series of industry-funded projects evaluating the use of a new treatment for Irritable Bowel Syndrome.

Research interests
  • Modelling in health care
  • Economic evaluation of cancer therapies
  • Economic evaluation of therapies for the prevention of coronary heart disease

Current projects

  • Cost-effectiveness of second-line treatments for chronic myeloid leukaemia
  • Cost-effectiveness of lapatinib in breast cancer
  • The economic impact of avoidable admissions in palliative care
  • Systematic review of utilities for breast cancer

Show: Featured publications All publications

Journal articles

Conference proceedings papers

All publications

Journal articles


  • Payne N, Akehurst R, Beard S, Brennan A, Calvert N, Chilcott J, Mccabe C, Paisley S & Ward S (2017) Supporting purchasing in acute specialties in the trent region, Controlling Costs: Strategic Issues in Health Care Management (pp. 118-130). RIS download Bibtex download

Conference proceedings papers

Scholarly editions


  • Harnan S, Cooper K, Meng Y, Ward S, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson I & Lorenz E Magnetic resonance imaging (MRI) for assessment of axillary lymph node metastases in breast cancer: systematic review. RIS download Bibtex download
Teaching interests

I deliver lectures on the critical appraisal of economic evaluations on the MSc Health Economics and Decision Modelling.